The board of directors of Perrigo Company (NYSE:PRGO; TASE:PRGO) has unanimously rejected the offer by Mylan NV to buy all its shares for $29 billion. Two weeks after receiving the offer, the pharmaceutical company told the NYSE last night that it felt the offer made by Mylan at a 25% premium of its share price, does not reflect the true value of the company, and does not serve the shareholders’ interests…
Please help us out :
Will you offer us a hand? Every gift, regardless of size, fuels our future.
Your critical contribution enables us to maintain our independence from shareholders or wealthy owners, allowing us to keep up reporting without bias. It means we can continue to make Jewish Business News available to everyone.
You can support us for as little as $1 via PayPal at [email protected].
Thank you.
Will you offer us a hand? Every gift, regardless of size, fuels our future.
Your critical contribution enables us to maintain our independence from shareholders or wealthy owners, allowing us to keep up reporting without bias. It means we can continue to make Jewish Business News available to everyone.
You can support us for as little as $1 via PayPal at [email protected].
Thank you.
Published by Globes [online], Israel business news – www.globes-online.com
–
